ChildStats.gov—Forum on Child and Family Statistics
faces of children
Home  |  About the Forum  |  Publications  |  Help
Search

America's Children: Key National Indicators of Well-Being, 2019

Immunization

Vaccination throughout childhood is essential because it helps provide immunity before children are exposed to potentially life-threatening diseases. Data on vaccination coverage are used to identify groups at risk of vaccine-preventable diseases, provide vaccination coverage estimates in an effort to monitor coverage, and evaluate the effectiveness of interventions designed to increase coverage.

Indicator HC3.A: Percentage of children ages 19–35 months with completed 4:3:1:3*:3:1:4 combined series of vaccinations by poverty status, 2009–2017
Indicator HC3.A: Percentage of children ages 19–35 months with completed 4:3:1:3*:3:1:4 combined series of vaccinations by poverty status, 2009–2017

NOTE: The 4:3:1:3*:3:1:4 series consists of 4 doses (or more) of diphtheria, tetanus toxoids, and pertussis (DTP) vaccines, diphtheria and tetanus toxoids (DT), or diphtheria, tetanus toxoids, and any acellular pertussis (DTaP) vaccines; 3 doses (or more) of poliovirus vaccines; 1 dose (or more) of any measles-containing vaccine; the full series of Haemophilus influenzaetype b (Hib) vaccines (3 or 4 doses, depending on product type); 3 doses (or more) of hepatitis B vaccines; 1 dose (or more) of varicella vaccine; and 4 doses (or more) of pneumococcal conjugate vaccines (PCV). The recommended immunization schedule for children is available at https://www.cdc.gov/vaccines/schedules/easy-to-read/child.html. Poverty status is based on family income and household size using U.S. Census Bureau poverty thresholds for the year of data collection.

SOURCE: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, National Immunization Survey—Child.

Indicator HC3.B: Percentage of adolescents ages 13–17 years with the routinely recommended-for-age vaccinations, 2006–2017
Indicator HC3.B: Percentage of adolescents ages 13–17 years with the routinely recommended-for-age vaccinations, 2006–2017

NOTE: Data collection for the 2006 and 2007 survey was only performed during the fourth quarter. The routine vaccination recommendation for children beginning at ages 11–12 includes tetanus-diphtheria-acellular pertussis (Tdap) vaccines, meningococcal conjugate (MenACWY) vaccines (1 dose each), and human papillomavirus (HPV) vaccines (2 doses or more). The recommended immunization schedule for adolescents is available at https://www.cdc.gov/vaccines/schedules/easy-to-read/preteen-teen.html.

SOURCE: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, National Immunization Survey—Teen.

  • Since 2009, the percentage of children ages 19–35 months who received the recommended combined 7-vaccine series (4:3:1:3*:3:1:4) has increased by 26 percentage points. The coverage rate was 70% in 2017.
  • Children living in families with incomes below the poverty threshold had a vaccination coverage rate of 63% in 2017, compared with 74% for children in families with incomes at or above the poverty level.
  • Since 2006, vaccination coverage for adolescents ages 13–17 has increased for all routinely recommended vaccinations for adolescents. In 2017, vaccination coverage for one dose (or more) of tetanus, diphtheria, and acellular pertussis (Tdap) was 89% and coverage for one dose (or more) of meningococcal conjugate (MenACWY) vaccine was 85%.
  • For adolescents ages 13–17, vaccination coverage for one dose (or more) of human papillomavirus (HPV) vaccine increased by an average of 3 percentage points annually from 2008 to 2017 for females and 9 percentage points annually from 2010 to 2017 for males.

table icon HC3A HTML Table | HC3B HTML Table